Related Experiment Video
Updated: Jun 10, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
965
Self-guided Knowledge-Injected Graph Neural Network for Alzheimer's Diseases.
Zhepeng Wang1, Runxue Bao2, Yawen Wu3
1George Mason University, Fairfax, VA 22032, USA.
Summary
This study introduces a self-guided knowledge-infused multimodal graph neural network (GNN) for Alzheimer's Disease (AD) analysis. The novel approach autonomously integrates domain knowledge from text to enhance GNN performance and interpretability in AD research.
Area of Science:
- Neuroscience
- Machine Learning
- Artificial Intelligence
Background:
- Graph neural networks (GNNs) excel at analyzing complex, irregular data structures.
- Standard GNNs require domain-specific knowledge for optimal performance in specialized fields like Alzheimer's Disease (AD) brain connectome analysis.
- Manual integration of AD expertise into GNNs is resource-intensive and requires significant specialist input.
Purpose of the Study:
- To develop a novel self-guided, knowledge-infused multimodal GNN framework for autonomous domain knowledge integration in AD research.
- To overcome the limitations of manual knowledge curation in GNN model development.
- To enhance the efficacy and interpretability of GNNs for AD analysis.
Main Methods:
- Conceptualized domain knowledge as natural language.
- Developed a specialized multimodal GNN framework to process natural language knowledge.
- Leveraged uncurated textual domain knowledge to guide the GNN's learning process.
- Compiled a literature dataset of AD publications and integrated it with real-world AD datasets.
Main Results:
- Demonstrated the framework's effectiveness in extracting curated knowledge from AD literature.
- Showcased the ability to provide graph-based explanations for domain-specific applications.
- Achieved enhanced GNN performance by utilizing extracted domain knowledge.
- Improved prediction interpretability in the context of AD.
Conclusions:
- The proposed self-guided knowledge-infused multimodal GNN autonomously integrates domain knowledge, reducing reliance on manual curation.
- This approach enhances GNN performance and interpretability for Alzheimer's Disease connectome analysis.
- The framework offers a scalable and efficient method for leveraging textual expertise in specialized machine learning applications.
Related Concept Videos
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165

